Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041703
Filing Date
2019-11-07
Accepted
2019-11-07 16:01:34
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cue-10q_20190930.htm 10-Q 1651135
2 EX-31.1 cue-ex311_8.htm EX-31.1 15563
3 EX-31.2 cue-ex312_7.htm EX-31.2 15800
4 EX-32.1 cue-ex321_6.htm EX-32.1 11288
5 GRAPHIC gf54pglrmrpx000001.jpg GRAPHIC 40572
  Complete submission text file 0001564590-19-041703.txt   5390691

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cue-20190930.xml EX-101.INS 903471
7 XBRL TAXONOMY EXTENSION SCHEMA cue-20190930.xsd EX-101.SCH 51097
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20190930_cal.xml EX-101.CAL 43264
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20190930_def.xml EX-101.DEF 145499
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20190930_lab.xml EX-101.LAB 372728
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20190930_pre.xml EX-101.PRE 282900
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 191200180
SIC: 2834 Pharmaceutical Preparations